Cargando…

Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research

The objective of this work is to review and assess the potential of [Formula: see text]:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of [Formula: see...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossin, Lily, Plokhikh, Igor, Christensen, Jeppe Brage, Gawryluk, Dariusz Jakub, Kitagawa, Yuuki, Leblans, Paul, Tanabe, Setsuhisa, Vandenbroucke, Dirk, Yukihara, Eduardo Gardenali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142933/
https://www.ncbi.nlm.nih.gov/pubmed/37109886
http://dx.doi.org/10.3390/ma16083051
_version_ 1785033730799173632
author Bossin, Lily
Plokhikh, Igor
Christensen, Jeppe Brage
Gawryluk, Dariusz Jakub
Kitagawa, Yuuki
Leblans, Paul
Tanabe, Setsuhisa
Vandenbroucke, Dirk
Yukihara, Eduardo Gardenali
author_facet Bossin, Lily
Plokhikh, Igor
Christensen, Jeppe Brage
Gawryluk, Dariusz Jakub
Kitagawa, Yuuki
Leblans, Paul
Tanabe, Setsuhisa
Vandenbroucke, Dirk
Yukihara, Eduardo Gardenali
author_sort Bossin, Lily
collection PubMed
description The objective of this work is to review and assess the potential of [Formula: see text]:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of [Formula: see text]:Ce,Li for OSL dosimetry, as reviewed in the literature and complemented by measurements of thermoluminescence spectroscopy, sensitivity, thermal stability, lifetime of the luminescence emission, dose response at high doses (>1000 Gy), fading and bleachability. Overall, compared with [Formula: see text] , for example, [Formula: see text]:Ce,Li shows a comparable OSL signal intensity following exposure to ionizing radiation, a higher saturation limit (ca 7000 Gy) and a shorter luminescence lifetime (31.5 ns). [Formula: see text]:Ce,Li is, however, not yet an optimum material for OSL dosimetry, as it exhibits anomalous fading and shallow traps. Further optimization is therefore needed, and possible avenues of investigation encompass gaining a better understanding of the roles of the synthesis route and dopants and of the nature of defects.
format Online
Article
Text
id pubmed-10142933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101429332023-04-29 Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research Bossin, Lily Plokhikh, Igor Christensen, Jeppe Brage Gawryluk, Dariusz Jakub Kitagawa, Yuuki Leblans, Paul Tanabe, Setsuhisa Vandenbroucke, Dirk Yukihara, Eduardo Gardenali Materials (Basel) Article The objective of this work is to review and assess the potential of [Formula: see text]:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of [Formula: see text]:Ce,Li for OSL dosimetry, as reviewed in the literature and complemented by measurements of thermoluminescence spectroscopy, sensitivity, thermal stability, lifetime of the luminescence emission, dose response at high doses (>1000 Gy), fading and bleachability. Overall, compared with [Formula: see text] , for example, [Formula: see text]:Ce,Li shows a comparable OSL signal intensity following exposure to ionizing radiation, a higher saturation limit (ca 7000 Gy) and a shorter luminescence lifetime (31.5 ns). [Formula: see text]:Ce,Li is, however, not yet an optimum material for OSL dosimetry, as it exhibits anomalous fading and shallow traps. Further optimization is therefore needed, and possible avenues of investigation encompass gaining a better understanding of the roles of the synthesis route and dopants and of the nature of defects. MDPI 2023-04-12 /pmc/articles/PMC10142933/ /pubmed/37109886 http://dx.doi.org/10.3390/ma16083051 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bossin, Lily
Plokhikh, Igor
Christensen, Jeppe Brage
Gawryluk, Dariusz Jakub
Kitagawa, Yuuki
Leblans, Paul
Tanabe, Setsuhisa
Vandenbroucke, Dirk
Yukihara, Eduardo Gardenali
Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
title Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
title_full Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
title_fullStr Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
title_full_unstemmed Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
title_short Addressing Current Challenges in OSL Dosimetry Using MgB(4)O(7):Ce,Li: State of the Art, Limitations and Avenues of Research
title_sort addressing current challenges in osl dosimetry using mgb(4)o(7):ce,li: state of the art, limitations and avenues of research
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142933/
https://www.ncbi.nlm.nih.gov/pubmed/37109886
http://dx.doi.org/10.3390/ma16083051
work_keys_str_mv AT bossinlily addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT plokhikhigor addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT christensenjeppebrage addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT gawrylukdariuszjakub addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT kitagawayuuki addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT leblanspaul addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT tanabesetsuhisa addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT vandenbrouckedirk addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch
AT yukiharaeduardogardenali addressingcurrentchallengesinosldosimetryusingmgb4o7celistateoftheartlimitationsandavenuesofresearch